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CC BY-NC-ND license.The Rancho Bernardo Study (RBS) [1] has had an
important and lasting contribution to the literature
addressing sex differences in cardiovascular disease and, in
particular, how diabetes modiﬁes these risks. It began as 1 of
the 12 LRC (Lipid Research Clinic) prevalence study sites
and was a unique cohort study in which 82% of a target
population was enrolled, resulting in low selection bias. RBS
was among the ﬁrst cohort studies to focus on sex differences
in the association of diabetes and cardiovascular disease and
has had lasting effects on how we diagnose and perhaps
manage women with diabetes. It was among the few studies
at the time that focused on older persons; thus, it broke new
ground in geriatric epidemiology as well.
RBS was the ﬁrst cohort study to perform oral glucose
tolerance tests to assess insulin resistance and diabetes. The
study documented important differences between men and
women in fasting glucose and impaired glucose tolerance,
including a diabetes detection bias in women because
a higher proportion of women than men had diabetes
diagnosed only after an oral glucose tolerance test. In addi-
tion to ﬁnding a source of underdetection of diabetes in
women, the RBS also documented a linear relationship in
menwith fasting glucose and heart diseasemortality risk, but
in women a threshold effect was found; an association
between fasting glucose and coronary heart disease (CHD)
mortality existed only after the fasting glucose level reached
100 mg/dl.
The RBS study also showed CHD mortality differences
in men and women, thereby showing that the presence of
diabetes eliminated cardioprotection in women. In their
JAMA publication [2] on this topic that examined 14-year
risk of fatal ischemic heart disease, the relative hazard asso-
ciated with diabetes after adjustment for age and other risk
factors was 1.9 in men and 3.3 in women. The RBS also
measured endogenous sex hormones using the most sensi-
tive and speciﬁc assays available at the time for total and
bioavailable testosterone and estradiol. Although they did
not ﬁnd a direct relationship between sex hormones and
CHD, they found evidence that perhaps the effect of
changing hormones, particularly in a post-menopausal state
in womenwasmediated through impaired glucose tolerance
and diabetes. The relationships found were complex. The
risk of diabetes was increased in men if their bioavailable
testosterone was in the lowest quartile and in women if their
bioavailable testosterone was in the highest quartile.
In addition, low levels of total testosterone were
signiﬁcantly associated with incident CHD events in the
RBS women. Therefore, both low and high testosterone
were associated with higher risk of CHD events in women,
high bioavailable testosterone was associated with obesity,GLOBAL HEART, VOL. 8, NO. 2, 2013
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low total testosterone may have a different mechanism.
RBS is a very important cohort study in delineating
differences in men and women in how diabetes modulates
risk for CHD. It helped close gaps in knowledge of how
diabetes eradicates cardioprotection in women. Observa-
tional studies, including the RBS, have been invaluable for
testing hypotheses among “real women seen in practice,”
who are often more representative than those selected for
clinical trials, often representing a wider socioeconomic
and ethnic distribution than that used in clinical trials.
Moreover, such studies will include those who may be
excluded from clinical trials, such as women with severe
menopausal symptoms, who are typically excluded from
clinical trials [3].
Whereas we have focused on the contributions the RBS
has made in the area of sex differences in diabetes and
cardiovascular disease, the study has made countless other
contributions that are too great tomention here. As a sampler,
most recently, the predictive role of biomarkers such as
troponin andN-terminal proeB-type natriuretic peptide have
been studied in relation to dementia [4] andmortality [5], and
factors such as abdominal obesity and kidney function have
been examined in relation to progression of atherosclerosis
measured bynovel factors such as coronary calciﬁcation [6,7].
In 2009, in her 2009 Distinguished Scientist Lecture
awarded by the American Heart Association, Dr. Barrett-
Connor described how her simple addition of fasting
glucose and information about diabetes to the LRC study in
Rancho Bernardo shaped what was to become among the
most pre-eminent studies examining sex differences in
coronary heart disease and diabetes that would ultimately
contribute greatly to awareness of the problems of diabetes
and heart disease in women [8]. With the many investi-
gators who have participated and continue to participate in
exploring new hypotheses in the RBS, the future of the
study, now in its ﬁfth decade, continues to hold great
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